Literature DB >> 8262331

Hepatic glutaminase expression: relationship to kidney-type glutaminase and to the urea cycle.

M Watford1.   

Abstract

Glutamine functions as a major transport form of nitrogen and carbon within the body. In the liver, glutamine is hydrolyzed by a unique liver-type, phosphate-activated glutaminase, and the end products of hepatic glutamine catabolism are glucose and urea. Other tissues possess a different, kidney-type, glutaminase isozyme. The predicted amino acid sequences for the two glutaminases show a high degree of identity, indicating that they are products of different but related genes. Hepatic glutaminase activity is increased during diabetes, starvation, and on feeding high-protein diets, and decreased on feeding low-protein diets, whereas renal glutaminase appears to be regulated only by changes in acid-base status. Changes in the rate of gene transcription are the principal mechanism responsible for the long-term regulation of hepatic glutaminase, but the renal enzyme is regulated at the level of mRNA turnover. The pattern of regulation of hepatic glutaminase parallels that seen for genes encoding key enzymes of gluconeogenesis and urea synthesis, and indicates coordinate regulation of expression in keeping with the role of hepatic glutamine catabolism in these pathways.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262331     DOI: 10.1096/fasebj.7.15.8262331

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

1.  Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT.

Authors:  Eva Parisi; Milica Bozic; Mercé Ibarz; Sara Panizo; Petya Valcheva; Blai Coll; Elvira Fernández; José M Valdivielso
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-09-07       Impact factor: 4.310

2.  Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.

Authors:  Sawako Suzuki; Tomoaki Tanaka; Masha V Poyurovsky; Hidekazu Nagano; Takafumi Mayama; Shuichi Ohkubo; Maria Lokshin; Hiroyuki Hosokawa; Toshinori Nakayama; Yutaka Suzuki; Sumio Sugano; Eiichi Sato; Toshitaka Nagao; Koutaro Yokote; Ichiro Tatsuno; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

3.  Rat hepatic glutaminase: identification of the full coding sequence and characterization of a functional promoter.

Authors:  M I Chung-Bok; N Vincent; U Jhala; M Watford
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.

Authors:  C Lobo; M A Ruiz-Bellido; J C Aledo; J Márquez; I Núñez De Castro; F J Alonso
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

5.  Co-expression of glutaminase K and L isoenzymes in human tumour cells.

Authors:  Cristina Pérez-Gómez; José A Campos-Sandoval; Francisco J Alonso; Juan A Segura; Elisa Manzanares; Pedro Ruiz-Sánchez; María E González; Javier Márquez; José M Matés
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

6.  Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix.

Authors:  M Nagaki; K Miki; Y I Kim; H Ishiyama; I Hirahara; H Takahashi; A Sugiyama; Y Muto; H Moriwaki
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

7.  Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells.

Authors:  B P Bode; W W Souba
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

Review 8.  Glutamine metabolism in advanced age.

Authors:  Dominique Meynial-Denis
Journal:  Nutr Rev       Date:  2016-03-02       Impact factor: 7.110

9.  Activation of hepatic glutaminase by spermine.

Authors:  Z Kovacevic; S H Day; V Collett; J T Brosnan; M E Brosnan
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

10.  Dietary supplementation with cholesterol and docosahexaenoic acid affects concentrations of amino acids in tissues of young pigs.

Authors:  Peng Li; Sung Woo Kim; Xilong Li; Sujay Datta; Wilson G Pond; Guoyao Wu
Journal:  Amino Acids       Date:  2008-10-30       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.